IP Library Granted Patent US 7,671,041
Granted Patent B2
US 7,671,041 · App. 11/455,239 · Granted Mar 2, 2010

Hydrolysate of avian cartilage, process of preparation and uses thereof

Assignee: Diana Naturals
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,671,041
App. No.
11/455,239
Granted
Mar 2, 2010
Kind
B2
Abstract

This invention relates to a hydrolysate of avian cartilage comprising 45% to 70% by weight of hydrolysed type II collagen, 9% to 15% by weight of chondroitin sulphate, 0.5% to 2% in weight of hyaluronic acid; with a composition of amino acids in which valine represents 2.7% to 3.3%, isoleucine represents 2.0 to 2.4, phenylalanine represents 2.2% to 2.6%, lysine represents 3.8% to 4.2%, tryptophane represents 0.4% to 0,6%, hydroxyproline represents 5.5% to 8.7%, hydroxylysine represents 0.7% to 1.8%, and in which the molar ratio between hydroxyproline and hydroxylysine is between 5.0 and 8.0; and having an average molecular weight of the peptidic fraction between 500 and 1000 Daltons. The invention also relates to a process for preparing said hydrolysate, and its use as a food complement, and/or as a medicament, particularly for treatment or prevention of joint pain.

Claims (29)

1. A hydrolysate of avian cartilage comprising a peptidic fraction and glycosaminoglycans, wherein:

a) it comprises:

45% to 70% by weight of hydrolysed type II collagen,

9% to 15% by weight of chondroitin sulphate,

0.5% to 2% by weight of hyaluronic acid;

b) said peptidic fraction comprises:

2.7% to 3.3% by weight of valine,

2.0% to 2.4% by weight of isoleucine,

2.2% to 2.6% by weight of phenylalanine,

3.8% to 4.2%, by weight of lysine

0.4% to 0.6% by weight of tryptophane,

5.5% to 8.7% by weight of hydroxyproline,

0.7% to 1 .8% by weight of hydroxylysine,

and the molar ratio of hydroxyproline to hydroxylysine is between 5.0 and 8.0;

c) the average molecular weight of said peptidic fraction is between 500 and 1000 Daltons.

2. The hydrolysate according to claim 1 , wherein it is prepared from a mix of 70%-100% by weight of bone and joint cartilage and 0%-30% by weight of sternum cartilage.

3. A process for preparing a hydrolysate of avian cartilage according to claim 1 , comprising:

a) supplying a raw material composed of 70%-100% by weight of bone and joint cartilage (including sternal) and 0%-30% by weight of sternum cartilage,

b) mixing this raw material with an aqueous solution with a pH between 5.5 and 7.5,

c) hydrolysing the mix of raw material in water with a proteolytic enzyme during 1 hour to 2 hours, preferably during 1 hour and 30 minutes to 2 hours, at a temperature between 65° C. and 75° C.,

d) inactivating the proteolytic enzyme for 10 to 20 minutes at least 85° C.,

e) filtering the reaction mix containing the hydrolysate,

f) concentrating the reaction mix,

g) performing final sterilization of the reaction mix at about 130° C. for at least about 30 seconds, and

h) drying the reaction mix to obtain the hydrolysate in powder form.

4. A food complement comprising the hydrolysate according to claim 1 .

5. A medicament comprising the hydrolysate according to claim 1 .

6. A method for treating joint pain, comprising administering to a patient an effective amount of the hydrolysate according to claim 1 .

7. The method according to claim 6 , wherein the origin of joint pain is degeneration of cartilage related to age, excessive strain of joints due to intensive practice of a sport, or excessive strain of joints due to obesity.

Assignments (2)
CHANGE OF NAME Recorded Dec 27, 2021
From: DIANA NATURALS
To: DIANA FOOD
Reel/Frame 058477/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2006
From: VOULAND, ERIC; BERGER, CELINE
To: DIANA NATURALS
Reel/Frame 018289/0148 →
Priority Claims (1)
FR 06 03547 · Apr 21, 2006 · national
Continuity (1)
Related Publication 20070293427A1 · Dec 20, 2007